how common is nausea with semaglutide Ozempic: a GLP-1 receptor agonist used for type 2 diabetes and cardiovascular risk reduction in selected patients, commonly causing nausea, vomiting, diarrhea, constipation, abdominal pain, reduced appetite, and weight loss Semaglutide Side Effects: What to

Description

Stay hydrated and manage side effects Common side effects of GLP-1 agonists include nausea, constipation and feeling overly full

Underlying health conditions can impact your ability to lose weight, such as: The extent to which these conditions impact your journey can depend on various factors, but you may need additional support or require more time for your body to recover

GLP-1 receptor agonists enhance glucose-dependent insulin secretion from pancreatic beta cells, suppress inappropriate glucagon release, and slow gastric emptying

We will continue to monitor clinical trial data, regulatory updates, and availability timelines as they develop.

Retatrutide timing for specific goals Your primary goal with retatrutide, whether weight loss , metabolic health improvement, or body recomposition, can influence which timing approach makes the most sense